![Dario Eklund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dario Eklund
Keine laufenden Positionen mehr
Vermögen: 3 Mio $ am 31.07.2026
Profil
Dario Eklund worked as Commercial Director at Novartis AG from 1994 to 2002.
From 2002 to 2004, worked as General Manager-Switzerland at Sanofi.
Held the position of VP-Business Development & Gintuit Business Unit at Organogenesis, Inc. from 2004 to 2014.
Worked as Head-Global Business Operations at Vifor Pharma Management AG from 2014 to 2019.
Served as Chief Commercial Officer at Corden Pharma Fribourg SA from 2017 to 2019.
Was a Member of the Supervisory Board at Vifor Fresenius Medical Care Renal Pharma Ltd. from 2017 to 2019.
Held the role of Chief Executive Officer at Santhera Pharmaceuticals Holding AG from 2019 to 2026.
Also worked as General Manager-Switzerland Region at Aventis Pharma AG.
Education includes graduate degree from Hanken Svenska Handelshögskolan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 148.372 ( 0,96 % ) | 3 Mio $ | 31.07.2026 |
Ehemalige bekannte Positionen von Dario Eklund
| Unternehmen | Position | Ende |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Vorstandsvorsitzender | 15.07.2026 |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Corporate Officer/Principal | 30.09.2019 |
| VIFOR PHARMA | Corporate Officer/Principal | 30.09.2019 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Direktor/Vorstandsmitglied | 01.01.2019 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Dario Eklund
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Aventis Pharma AG | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Hanken Svenska Handelshögskolan
 Hanken Svenska Handelshögskolan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
